- Molecular NameAcipimox
- SynonymNA
- Weight154.125
- Drugbank_IDN/A
- ACS_NO51037-30-0
- Show 3D model
- LogP (experiment)N/A
- LogP (predicted, AB/LogP v2.0)0.64
- pkaN/A
- LogD (pH=7, predicted)-2.91
- Solubility (experiment)9.95 mg/ml
- LogS (predicted, ACD/Labs)(ph=7)0.81
- LogSw (predicted, AB/LogsW2.0)116.09
- Sw (mg/ml) (predicted, ACD/Labs)314.84
- No.of HBond Donors1
- No.of HBond Acceptors5
- No.of Rotatable Bonds1
- TPSA75.65
- StatusN/A
- AdministrationN/A
- PharmacologyA niacin derivative used as a hypolipidemic agent.
- Absorption_value95.0
- Absorption (description)N/A
- Caco_2N/A
- Bioavailability90.0
- Protein bindingN/A
- Volume of distribution (VD)N/A
- Blood/Plasma Partitioning ratio (D_blood)N/A
- MetabollsmN/A
- Half lifeN/A
- ExcretionN/A
- Urinary ExcretionN/A
- CleranceN/A
- ToxicityN/A
- LD50 (rat)N/A
- LD50 (mouse)N/A